Repository logo
 

Infectious prions and proteinopathies

dc.contributor.authorBarron, Ronaen
dc.date.accessioned2022-12-16T14:24:25Z
dc.date.available2022-12-16T14:24:25Z
dc.date.issued2017-03-10
dc.descriptionRona Barron - ORCID: 0000-0003-4512-9177 https://orcid.org/0000-0003-4512-9177en
dc.description.abstractTransmissible spongiform encephalopathies (TSEs) are caused by an infectious agent that is thought to consist of only misfolded and aggregated prion protein (PrP). Unlike conventional micro-organisms, the agent spreads and propagates by binding to and converting normal host PrP into the abnormal conformer, increasing the infectious titre. Synthetic prions, composed of refolded fibrillar forms of recombinant PrP (rec-PrP) have been generated to address whether PrP aggregates alone are indeed infectious prions. In several reports, the development of TSE disease has been described following inoculation and passage of rec-PrP fibrils in transgenic mice and hamsters. However in studies described here we show that inoculation of rec-PrP fibrils does not always cause clinical TSE disease or increased infectious titre, but can seed the formation of PrP amyloid plaques in PrP-P101L knock-in transgenic mice (101LL). These data are reminiscent of the “prion-like” spread of misfolded protein in other models of neurodegenerative disease following inoculation of transgenic mice with pre-formed amyloid seeds. Protein misfolding, even when the protein is PrP, does not inevitably lead to the development of an infectious TSE disease. It is possible that most in vivo and in vitro produced misfolded PrP is not infectious and that only a specific subpopulation is associated with infectivity and neurotoxicity.en
dc.description.ispublishedpub
dc.description.number1en
dc.description.statuspub
dc.description.urihttps://doi.org/10.1080/19336896.2017.1283464en
dc.description.volume11en
dc.format.extent40-47en
dc.identifierhttps://eresearch.qmu.ac.uk/handle/20.500.12289/12695/12695.pdf
dc.identifier.citationBarron, R.M. (2017) ‘Infectious prions and proteinopathies’, Prion, 11(1), pp. 40–47. Available at: https://doi.org/10.1080/19336896.2017.1283464.en
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/12695
dc.identifier.urihttps://doi.org/10.1080/19336896.2017.1283464
dc.language.isoenen
dc.publisherTaylor and Francisen
dc.relation.ispartofPrionen
dc.rights© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.rights.licenseAttribution 4.0 International (CC BY 4.0)
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAmyloiden
dc.subjectPrionen
dc.subjectPrion-likeen
dc.subjectSynthetic prionsen
dc.subjectTSEen
dc.titleInfectious prions and proteinopathiesen
dc.typeArticleen
dcterms.accessRightspublic
dcterms.dateAccepted2017-01-13
refterms.accessExceptionNAen
refterms.depositExceptionNAen
refterms.panelUnspecifieden
refterms.technicalExceptionNAen
refterms.versionVoRen
rioxxterms.typeJournal Article/Reviewen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
12695.pdf
Size:
552.12 KB
Format:
Adobe Portable Document Format
Description:
Published Version